NCT03745781终止早期 1 期
Open-Label Placebo for Functional Dyspepsia
适应症
干预措施
相关药物
试验速览
- 阶段
- 早期 1 期
- 状态
- 终止
- 入组人数
- 21
- 试验地点
- 1
- 主要终点
- dyspepsia severity on a VAS from 0-100
研究概览
简要总结
The study is evaluating the efficacy of open-label placebo for the treatment of functional dyspepsia.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Functional Dyspepsia
排除标准
- 未提供
研究组 & 干预措施
open-label placebo
Experimental
open-label placebo
干预措施: Placebos (Drug)
结局指标
主要结局
dyspepsia severity on a VAS from 0-100
时间窗: 3 weeks
How severe have your dyspepsia symptoms been over the past 7 days (on a VAS from 0-100)?
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
A Study of Glutamine to Treat Intestinal Permeability in Functional DyspepsiaFunctional DyspepsiaNCT05655819David J. Cangemi12
Unknown
不适用
Treatment of Functional Dyspepsia With Genuine Regional Rhizoma AtractylodisEfficiency of Genuine Regional and Non-genuine Regional Rhizoma Atractylodis in Treating FDNCT03173183China Academy of Chinese Medical Sciences90
招募中
不适用
Clinical Trial for the Evaluation of the Efficacy and Safety of EDL on DyspepsiaFunctional DyspepsiaNCT04482478Seoul National University Bundang Hospital100
已完成
不适用
Double blind, randomized Placebo-controlled study for FDfunctional dyspepsiaJPRN-UMIN000001759Office of the ELF study200
终止
不适用
Harnessing the Effect of an Open-Label Placebo on Fatigue in Cancer SurvivorsFatigue in Cancer SurvivorsNCT02452710Dana-Farber Cancer Institute40